VRV-18091-77056 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-01
Dose 1 — Moderna
2021-04-03
Registered in v-safe
2021-04-03
Survey response — days 1–6 daily, dose 1
MedDRA: Erythema — Feeling: Good · Site: Pain

Free text: Red face but no fever

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-01
Survey response — 3 months, dose 1
MedDRA: Uterine dilation and curettage, Vaginal haemorrhage — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Symptoms: Excessive vaginal bleeding requiring a D &c · Healthcare visit (other): D&C

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-01
Report sent to call center — 3 months, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-06
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2021-10-02
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2022-04-03
Health check-in — 12 months, dose 1
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-01	Moderna

Call center

Reported	Outcome	VAERS-related outcome
2021-07-01	Successful 2021-07-06	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 6 — days 1–6 daily, dose 1

2021-04-03

Systemic reaction (other): Red face but no fever

Release 9 — 3 months, dose 1

2021-07-01

Symptoms: Excessive vaginal bleeding requiring a D &c

Healthcare visit (other): D&C

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Uterine dilation and curettage	✓	✓	✓
SD	Uterine dilation and curettage	✓	✓	✓
SD	Vaginal haemorrhage	✓	✓	✓
SRO	Erythema	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release